How to Fight Medicare Fraud & Protect your Identity

Breaking News
938

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Happy National Consumer Protection Week! Now’s a great time to brush up on your Medicare rights and protections, and take action to protect your identity.

Here are 3 things to do:

  1. Protect your identity. Identity theft happens when someone uses your personal information without your consent to commit fraud or other crimes. Guard your Medicare Number and card, and keep your Social Security Number safe.
  2. Help fight Medicare fraud. Use your MyMedicare account to stay on top of your claims. If you find errors or fraud, report it to us. Don’t have a MyMedicare account yet? Sign up for free at MyMedicare.govtoday.
  3. Know your rights. You have certain rights and protections designed to make sure you get the health care services the law says you can get.

Sincerely, The Medicare Team

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Ophthalmologist Surgeon Revolutionizing Cornea Transplants in the Valley
Next article
‘If They can Dream, They can Achieve’: STC Instructor Hoping to Inspire others by Sharing Personal Story of Earning Healthcare Degree later in Life

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -